Gaius Therapeutics, Inc, — Form D

Gaius Therapeutics, Inc, of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-14. The offering totals $250K, of which $60K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-05-14
• Form: D
• Accession: 0002132841-26-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $250K
• Amount sold: $60K
• Remaining: $190K
• Investors: 2
• Revenue range: Decline to Disclose
• SEC file number: 021-583983

Issuer

• Name: Gaius Therapeutics, Inc,
• CIK: 0002132841
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 9276 SCRANTON ROAD, SUITE 500 9276 Scranton Rd, Suite 500, SAN DIEGO, CA, 92121
• Phone: 650-255-8226

Officers, directors & promoters (6)

More

• CIK 2132841 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search